281 related articles for article (PubMed ID: 33509772)
1. Lung microbiome mediates the progression from chronic obstructive pulmonary disease to lung cancer through inflammation.
Wang YJ; Wu SS; Chu J; Kong XY
Yi Chuan; 2021 Jan; 43(1):30-39. PubMed ID: 33509772
[TBL] [Abstract][Full Text] [Related]
2. Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
Wang L; Hao K; Yang T; Wang C
Chin Med J (Engl); 2017 Sep; 130(17):2107-2111. PubMed ID: 28741603
[TBL] [Abstract][Full Text] [Related]
3. The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD): Current perspectives.
Dima E; Kyriakoudi A; Kaponi M; Vasileiadis I; Stamou P; Koutsoukou A; Koulouris NG; Rovina N
Respir Med; 2019 Oct; 157():1-6. PubMed ID: 31450162
[TBL] [Abstract][Full Text] [Related]
4. Chronic obstructive pulmonary disease and infection. Disruption of the microbiome?
Sethi S
Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S43-7. PubMed ID: 24437405
[TBL] [Abstract][Full Text] [Related]
5. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease.
Liu J; Ran Z; Wang F; Xin C; Xiong B; Song Z
Crit Rev Microbiol; 2021 Feb; 47(1):1-12. PubMed ID: 33040638
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
[TBL] [Abstract][Full Text] [Related]
7. The lung microbiome and exacerbations of COPD.
Dy R; Sethi S
Curr Opin Pulm Med; 2016 May; 22(3):196-202. PubMed ID: 26964078
[TBL] [Abstract][Full Text] [Related]
8. Lung microbiome, gut-lung axis and chronic obstructive pulmonary disease.
Gokulan K; Joshi M; Khare S; Bartter T
Curr Opin Pulm Med; 2022 Mar; 28(2):134-138. PubMed ID: 34907959
[TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians.
Luo L; Tang J; Du X; Li N
Respir Med; 2024; 225():107586. PubMed ID: 38460708
[TBL] [Abstract][Full Text] [Related]
10. Bacterial microbiome of lungs in COPD.
Sze MA; Hogg JC; Sin DD
Int J Chron Obstruct Pulmon Dis; 2014; 9():229-38. PubMed ID: 24591822
[TBL] [Abstract][Full Text] [Related]
11. COPD and the microbiome.
Mammen MJ; Sethi S
Respirology; 2016 May; 21(4):590-9. PubMed ID: 26852737
[TBL] [Abstract][Full Text] [Related]
12. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
14. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Huang YJ; Boushey HA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
[TBL] [Abstract][Full Text] [Related]
15. Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease.
Kayongo A; Robertson NM; Siddharthan T; Ntayi ML; Ndawula JC; Sande OJ; Bagaya BS; Kirenga B; Mayanja-Kizza H; Joloba ML; Forslund SK
Front Immunol; 2022; 13():1085551. PubMed ID: 36741369
[TBL] [Abstract][Full Text] [Related]
16. Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.
Mendez R; Banerjee S; Bhattacharya SK; Banerjee S
IUBMB Life; 2019 Feb; 71(2):152-165. PubMed ID: 30466159
[TBL] [Abstract][Full Text] [Related]
17. Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease.
Sze MA; Dimitriu PA; Suzuki M; McDonough JE; Campbell JD; Brothers JF; Erb-Downward JR; Huffnagle GB; Hayashi S; Elliott WM; Cooper J; Sin DD; Lenburg ME; Spira A; Mohn WW; Hogg JC
Am J Respir Crit Care Med; 2015 Aug; 192(4):438-45. PubMed ID: 25945594
[TBL] [Abstract][Full Text] [Related]
18. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease.
Bowerman KL; Rehman SF; Vaughan A; Lachner N; Budden KF; Kim RY; Wood DLA; Gellatly SL; Shukla SD; Wood LG; Yang IA; Wark PA; Hugenholtz P; Hansbro PM
Nat Commun; 2020 Nov; 11(1):5886. PubMed ID: 33208745
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between the lung microbiome and lung cancer.
Meng Y; Mao Y; Tang Z; Qiu X; Bajinka O; Tan Y; Song Z
Microb Pathog; 2023 May; 178():106062. PubMed ID: 36914054
[TBL] [Abstract][Full Text] [Related]
20. The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients.
Kim HJ; Kim YS; Kim KH; Choi JP; Kim YK; Yun S; Sharma L; Dela Cruz CS; Lee JS; Oh YM; Lee SD; Lee SW
Exp Mol Med; 2017 Apr; 49(4):e316. PubMed ID: 28408748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
